Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$92.57 - $107.37 $379,537 - $440,217
4,100 Added 38.68%
14,700 $1.56 Million
Q1 2024

May 15, 2024

BUY
$95.27 - $108.47 $1.01 Million - $1.15 Million
10,600 New
10,600 $1.03 Million
Q1 2023

May 15, 2023

SELL
$80.03 - $92.81 $1.58 Million - $1.84 Million
-19,800 Reduced 54.11%
16,793 $1.54 Million
Q4 2022

Feb 14, 2023

BUY
$75.55 - $92.52 $725,280 - $888,192
9,600 Added 35.56%
36,593 $3.32 Million
Q3 2022

Nov 14, 2022

BUY
$74.61 - $87.26 $2.01 Million - $2.36 Million
26,993 New
26,993 $2.05 Million
Q2 2022

Aug 15, 2022

SELL
$80.52 - $93.75 $1.34 Million - $1.56 Million
-16,617 Closed
0 $0
Q1 2022

May 16, 2022

BUY
$80.11 - $90.62 $1.33 Million - $1.51 Million
16,617 New
16,617 $1.46 Million
Q4 2020

Feb 12, 2021

SELL
$78.07 - $94.43 $563,118 - $681,123
-7,213 Closed
0 $0
Q3 2020

Nov 12, 2020

BUY
$82.14 - $91.0 $592,475 - $656,383
7,213 New
7,213 $627,000
Q1 2020

May 15, 2020

SELL
$70.67 - $99.01 $494,548 - $692,871
-6,998 Closed
0 $0
Q4 2019

Feb 14, 2020

SELL
$84.35 - $95.37 $1.74 Million - $1.96 Million
-20,600 Reduced 74.64%
6,998 $663,000
Q3 2019

Nov 13, 2019

BUY
$85.54 - $94.26 $1.91 Million - $2.1 Million
22,300 Added 420.91%
27,598 $2.4 Million
Q2 2019

Aug 13, 2019

BUY
$75.4 - $92.8 $399,469 - $491,654
5,298 New
5,298 $484,000
Q1 2019

May 14, 2019

SELL
$75.32 - $86.15 $338,939 - $387,675
-4,500 Closed
0 $0
Q4 2018

Feb 13, 2019

BUY
$73.66 - $82.02 $331,470 - $369,090
4,500 New
4,500 $386,000
Q3 2018

Nov 14, 2018

SELL
$66.94 - $77.43 $723,755 - $837,173
-10,812 Closed
0 $0
Q2 2018

Aug 14, 2018

SELL
$64.91 - $73.36 $676,037 - $764,044
-10,415 Reduced 49.06%
10,812 $817,000
Q1 2018

May 15, 2018

BUY
$70.39 - $84.15 $1.49 Million - $1.79 Million
21,227 New
21,227 $1.72 Million
Q4 2017

Feb 12, 2018

SELL
$72.33 - $77.64 $949,475 - $1.02 Million
-13,127 Closed
0 $0
Q3 2017

Nov 14, 2017

BUY
$74.14 - $77.27 $973,235 - $1.01 Million
13,127
13,127 $1.13 Million

Others Institutions Holding NVS

About NOVARTIS AG


  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $212B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Bayesian Capital Management, LP Portfolio

Follow Bayesian Capital Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bayesian Capital Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Bayesian Capital Management, LP with notifications on news.